Neogenomics (NEO) Non-Current Assets (2010 - 2026)

Neogenomics (NEO) has 17 years of Non-Current Assets data on file, last reported at $970.8 million in Q2 2026.

• Quarterly Non-Current Assets fell 3.06% year-over-year to $970.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $970.8 million (down 3.06% YoY) and the FY2025 annual result came in at $983.5 million, down 5.61% from the prior year.
• Non-Current Assets was little changed at $970.8 million in Q2 2026, from $972.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.2 billion in Q1 2022 to a low of $970.8 million in Q2 2026.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets surged 113.61% — and 2025, when it decreased 5.61%.
• Tracing NEO's Non-Current Assets over 5 years: stood at $1.1 billion in 2022, then fell by 4.44% to $1.1 billion in 2023, then fell by 3.91% to $1.0 billion in 2024, then retreated by 5.61% to $983.5 million in 2025, then slipped by 1.3% to $970.8 million in 2026.
• The last three Non-Current Assets figures came in at $970.8 million (Q2 2026), $972.8 million (Q1 2026), and $983.5 million (Q4 2025), per Business Quant data.